896684-04-1

BTD is a selective transient receptor potential canonical 5 (TRPC5) activator. BTD can be used for the research of neurological disease[1].

BTD is a potent and selective activator of the transient receptor potential canonical channel 5 (TRPC5). BTD can also activate heteromeric channels composed of TRPC5 and its closest relatives TRPC1 or TRPC4.

Store at -20°C

[1] Beckmann H,et al. A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels. Cell Calcium. 2017;66:10-18. DOI:10.1016/j.ceca.2017.05.012